NEUKINE 300 MCG (VIAL)

Product Description

. What is Neukine 300 Vial?
Neukine 300 Vial contains Filgrastim 300 mcg, a recombinant granulocyte colony-stimulating factor (G-CSF).

2. What is Neukine 300 used for?
It is used to help increase neutrophil counts and reduce the risk or duration of neutropenia in appropriate patients.

3. How does Neukine 300 work?
Filgrastim stimulates the bone marrow to produce and release more neutrophils, which help the body fight infections.

4. How is Neukine 300 administered?
It may be administered subcutaneously or intravenously, as directed by the treating physician.

5. What is the usual dose of Neukine 300?
The dose depends on the indication, patient's weight, blood counts, and treatment regimen. The treating physician determines the appropriate dose.

6. When is it given after chemotherapy?
For chemotherapy-induced neutropenia, filgrastim is generally initiated at least 24 hours after cytotoxic chemotherapy, according to the prescribed treatment protocol.

7. What are the common side effects?
Common side effects can include bone pain, musculoskeletal pain, headache, and injection-site reactions.

8. Why can Neukine cause bone pain?
Because filgrastim stimulates the bone marrow to increase production of neutrophils, some patients may experience bone or musculoskeletal pain.

9. Can Neukine 300 be given during chemotherapy?
The timing depends on the chemotherapy regimen. It should be used according to the oncologist's prescribed schedule.

10. How should Neukine 300 Vial be stored?
Filgrastim products are generally stored at 2C8C and protected from light. Do not freeze. Follow the product's approved storage instructions.

11. Can Neukine 300 be used without a prescription?
No. It should be administered under appropriate medical supervision.

12. What precautions should be taken before using Neukine 300?
The doctor should be informed about any previous reactions to filgrastim or related medicines, ongoing medical conditions, and current treatments.

13. Can the dose be repeated if the white blood cell count remains low?
Dose and duration should be determined using blood-count monitoring and the patient's clinical condition. Do not repeat or increase the dose without medical advice.

14. What should be done if a dose is missed?
Contact the treating healthcare professional for instructions. Do not take an additional dose to compensate unless advised.